首页> 外国专利> A NOVEL METHOD FOR ISOLATION OF ANTHRACENE MONOHYDRATE ALKALOID FROM THE TUBERS OF STEPHANIA GLABRA FOR THE TREATMENT OF DIABETES MELLITUS

A NOVEL METHOD FOR ISOLATION OF ANTHRACENE MONOHYDRATE ALKALOID FROM THE TUBERS OF STEPHANIA GLABRA FOR THE TREATMENT OF DIABETES MELLITUS

机译:一种从Stephania Glabra胎管中分离出蒽酮一水合碱的新型方法,用于治疗糖尿病

摘要

Stephania glabra (Roxb.) Miers (Menispermaceae) is used primarily to cure diabetes. Alkaloids are considered to be responsible for its pharmacological activity. (-) 2,3,8,9-Tetramethoxy-6, 6a, 7, 12-tetrahydro-5H-12a - aza - benzo[a] anthracene monohydrate alkaloid having potent antidiabetic activity was isolated from the tubers of Stephania glabra and characterized by IR, 1H - NMR, 13C - NMR, elemental analysis, mass spectra and X — ray crystallographic analysis. Antidiabetic activity of isolated alkaloid was carried out in alloxan induced diabetic rats. The isolated alkaloid showed a dose dependent mild hypoglycemic effect starting from the first hour to 24th hr (38.5%) of the experiment. The results were significant and comparable with the effect of commercial oral hypoglycemic drug, glibenclamide which showed 46.9% reduction under similar conditions.
机译:Stephania glabra(Roxb。)Miers(Menispermaceae)主要用于治疗糖尿病。生物碱被认为是其药理活性的原因。从Stephania glabra的块茎中分离出具有强效抗糖尿病活性的(-)2,3,8,9-四甲氧基-6,6a,7,12-四氢-5H-12a-氮杂-苯并[a]蒽一水合物生物碱,通过IR,1 H-NMR,13 C-NMR,元素分析,质谱和X-射线晶体学分析。分离的生物碱的抗糖尿病活性在四氧嘧啶诱导的糖尿病大鼠中进行。从实验的第一小时到第24小时(38.5%),分离出的生物碱显示出剂量依赖性的轻度降血糖作用。结果是显着的,并且与商业口服降糖药格列本脲的效果相当,后者在相似条件下降低了46.9%。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号